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1. Introduction
Gastric mucosal integrity is maintained by multiple factors, including both paracrine and
neuronal factors [1-4]. The former includes prostaglandins (PGs) [1] and nitric oxide (NO) [2],
while capsaicin-sensitive afferent neurons play a central role in neuronal protection in the
stomach [3]. Previous studies demonstrated that capsaicin, a selective stimulator of these
afferent neurons, protected the gastric mucosa against various ulcerogenic stimuli such as
nectrotizing agents [3]. The protective effects of capsaicin were shown to be mediated by these
afferent neurons because they were completely attenuated by the chemical ablation of these
neurons following a pretreatment with a large dose of capsaicin [3, 5]. The binding site of
capsaicin has been cloned and named the transient receptor potential vaniloid type 1 receptor
(TRPV1), a nonselective cationic channel [6]. Capsaicin is assumed to stimulate these afferent
neurons by activating TRPV1, which results in the liberation of the neurotransmitter, calcitonin
gene-related peptide (CGRP) and gastric protection.
Several studies, including our own, have showed that the protective effects of capsaicin were
mitigated by the prior administration of indomethacin, which indicated the involvement of
endogenous PGs in this action [6-9]. Endogenous PGs were previously shown to sensitize
sensory neurons to nociceptive stimuli [10, 11]. Therefore, endogenous PGs are assumed to
play a supportive role in the mechanism underlying capsaicin-induced gastric protection,
possibly by sensitizing these afferent neurons, because capsaicin-induced gastric cytoprotec‐
tion was shown to be attenuated by indomethacin.
On the other hand, recent pharmacological studies have classified PGE2 receptors into four
specific G protein-coupled subtypes, EP1 to EP4 [12]. The distribution of these receptors is
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
considered to explain the multiple effects of PGE2 in various tissues including the gastroin‐
testinal tract. Mice lacking various receptors for prostanoids have been established [13, 14],
and the roles of specific PG receptors in the various biological actions of PGs have been
demonstrated using these "knockout mice" [15]. We performed a series of experiments to
identify the EP receptor subtypes mediating the gastrointestinal protection afforded by PGE2
using various models in both rats and EP receptor knockout mice, and found that PGE2,
administered exogenously or generated endogenously, provided gastric protection against
HCl/ethanol mediated by EP1 receptors [16, 17]. However, the relationship between the EP
receptor subtype and facilitation of capsaicin-induced gastric protection by PGs remains
unknown.
We here investigated the role of endogenous PGs in the gastric protective action of capsaicin
against HCl/ethanol-induced damage in rats, mainly in relation to PGE2 and EP receptors.
Furthermore, because an animal model lacking various receptors for prostanoids is now
available [13, 15, 18], we also evaluated the protective activity of capsaicin in knockout mice
lacking EP1 or EP3 receptors and also in some cases IP receptors. In addition, we also examined
the gastric hyperemic response to capsaicin in these knockout mice in order to provide
functional evidence for the modulatory role of PGs in capsaicin-induced protective effects.
2. Methods
ANIMALS: Male Sprague-Dawley rats (200-220 g) and C57BL/6 mice (25-30 g) were used. Mice
lacking the EP1, EP3, or IP receptors were generated as described previously [13, 15, 19, 20].
In brief, the mouse genes encoding the EP1, EP3, and IP receptors were individually disrupted,
and chimaeric mice were generated. These animals were then back crossed with C57BL/6 mice,
and the resulting heterozygous litter mates [EP1 (+/-), EP3 (+/-) or IP (+/-), ] were bred to
produce homozygous EP1 (-/-), EP3 (-/-), or IP (-/-) mice. Homozygous mice were born at the
predicted Mendelian frequency, grew normally, lived longer than 1 year and were fertile. The
distribution of the EP1, EP3, and IP receptor genes was verified by northern blot hybridization,
which failed to detect messenger RNAs encoding the respective receptors in EP1 (-/-), EP3 (-/-),
and IP (-/-) mice. These knockout mice were deprived of food, but allowed free access to tap
water for 18 hr before the experiments. All studies were performed using 4~8 animals per
group.
INDUCTION OF GASTRIC LESIONS: Rats were administered 1 ml of HCl/ethanol (60% in
150 mM HCl) p.o. through esophageal intubation, and killed 1 hr later under deep ether
anesthesia. The stomachs were removed, inflated by injecting 10 ml of 1% formalin for 10 min
to fix the tissue walls, and opened along the greater curvature. The area (mm2) of hemorrhagic
lesions that developed in the stomach was measured under a dissecting microscope with a
square grid (x10). Capsaicin (1-10 mg/kg) was given p.o. 30 min before the administration of
HCl/ethanol. PGE2 (0.3 mg/kg) was given i.v. 10 min prior to the HCl/ethanol treatment. In
some cases, indomethacin (5 mg/kg) or ONO-AE-829 (5 and 10 mg/kg), the EP1 receptor
antagonist [20], was given s.c. 30 min before the administration of PGE2 or capsaicin. In
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addition, the protective effects of PGE2 and capsaicin on HCl/ethanol were also examined in
rats with the chemical ablation of capsaicin-sensitive sensory neurons. Chemical deafferenta‐
tion was induced by s.c. injections of capsaicin once a day for three consecutive days (total
dose: 100 mg/kg) 2 weeks before the experiment [5]. All capsaicin injections were performed
under ether anesthesia, and rats were pretreated with terbutaline (0.1 mg/kg, i.m.) and
aminophylline (10 mg/kg, i.m.) to counteract the respiratory impairment associated with
capsaicin injections. The effectiveness of the treatment was tested by examining protective
wiping movements of the eye. In a separate experiment, we examined the rescue effect of
various subtype-specific EP agonists on the protective effects of capsaicin in indomethacin-
treated rats. Animals were first administered indomethacin (5 mg/kg) s.c., followed by
capsaicin p.o. 30 min later, and were then given HCl/ethanol p.o. 30 min following the capsaicin
treatment. Butaprost (an EP2 agonist: 3 mg/kg), ONO-NT-012 (an EP3 agonist: 3 mg/kg) or 11-
deoxy PGE1 (an EP3/EP4 agonist: 1 mg/kg) was administered i.v. 10 min before the capsaicin
treatment. Animals were killed 1 hr after the administration of HCl/ethanol. In another
experiment, wild-type mice and EP1, EP3, or IP receptor knockout mice were administered
HCl/ethanol p.o. in a volume of 0.3 ml, and killed 1 hr later [16]. The stomach was then removed
and treated with formalin, and the mucosa was examined for hemorrhagic lesions under a
dissecting microscope, as described previously. Capsaicin (10 mg/kg) was given p.o. to half of
the animals in each group 30 min before the administration of HCl/ethanol. In addition,
indomethacin (5 mg/kg) or ONO-AE-829 (10 mg/kg) was given s.c. 30 min before the admin‐
istration of capsaicin in wild-type mice.
MEASUREMENT OF GASTRIC MUCOSAL BLOOD FLOW (GMBF): GMBF was measured
in both wild type mice and EP1-, EP3-, or IP-receptor knockout mice according to methods
described in our previous study [21, 22]. Under urethane anesthesia, the abdomen was opened
through a midline incision, and the stomach exposed, mounted on an ex-vivo chamber (the
exposed area; 0.7 mm2), and superfused at a rate of 0.5 ml/min. Gastric mucosal blood flow
was measured by a laser Doppler flowmeter (ALF-21, Advance, Tokyo, Japan) and by placing
a probe gently on the surface of the corpus mucosa using a balance (Medical Agent, Kyoto,
Japan). Changes in mucosal blood flow were monitored on a recorder (U-228, Tokai-irika,
Tokyo, Japan). After mucosal blood flow had stabilized, the solution in the chamber was
withdrawn, and the mucosa was then exposed to 0.2 ml of cicaprost, a PGI2 analogue (5 µg/
ml), or capsaicin (1 mg/ml) for 10 min. After the application of these agents, the mucosa was
rinsed with saline, another 0.2 ml of saline was instilled, and perfusion was resumed. Indo‐
methacin (5 mg/kg) was given s.c. to some of wild type mice 30 min before the application of
capsaicin.
MEASUREMENT OF MUCOSAL PGE2 AND 6-keto PGF1< LEVELS: PGE2 levels in the rat
gastric mucosa and those of 6-keto PGF1α in the mouse stomach were measured 30 min after
the p.o. administration of capsaicin (10 mg/kg). Some of the rats used were pretreated with
caspsaicin for sensory deafferentation. In some cases, indomethacin (5 mg/kg) was adminis‐
tered s.c. 30 min before the capsaicin treatment. Under ether anesthesia, the stomachs were
quickly removed, opened along the greater curvature, and rinsed with ice-cold saline. To




with a rubber band, and placed in hexane-frozen Dry Ice and acetone. These glasses were
separated, and the mucosa was collected, weighed, and put in a tube containing 100% ethanol
plus 0.1 M indomethacin [17, 23]. The samples were then homogenized, and centrifuged for
10 min at 12000 g at 4°C. The supernatant of each sample was used to determine PGE2 and 6-
keto PGF1α levels by EIA using PGE2-and 6-keto PGF1<-kits, respectively (Cayman Chemical
Co., Ann Arbor, MI).
PREPARATION OF DRUGS: The drugs used in the present study were capsaicin (Nakarai
Tesque, Kyoto, Japan), prostaglandin E2 (PGE2), 11-deoxy prostaglandin E1 (11-deoxy PGE1)
(Funakoshi, Tokyo, Japan), ONO-AE-829, butaprost, and ONO-NT-012 (Ono, Osaka, Japan),
terbutaline (Fujisawa, Osaka, Japan), aminophylline (Eisai, Tokyo, Japan), and indomethacin
(Sigma Chemicals, St. Louis, Mo). Capsaicin was dissolved in Tween 80-ethanol solution (10%
ethanol, 10% Tween 80, 80% saline, w/w) for s.c. injections, while indomethacin was suspended
in saline with a drop of Tween 80 (Wako, Osaka, Japan). ONO-AE-829 was dissolved in saline.
PGE2 and other EP receptor ligands were first dissolved in absolute ethanol and then diluted
with saline to the desired concentration. Each agent was prepared immediately before use and
given in a volume of 0.5 ml per 100 g body weight (rat) or 0.1 ml per 10 g body weight (mouse)
for its p.o. and s.c. administration, respectively, and given i.v. in a volume of 0.1 ml per 100 g
body weight (rat). Control animals received saline instead of the active agent.
STATISTICS: Data are presented as the mean±SE for 4~8 animals per group. Statistical
analyses were performed using a two-tailed Dunnett's multiple comparison test, and values
of P<0.05 were regarded as significant.
3. Results
3.1. Effect of capsaicin on HCl/ethanol-induced gastric lesions in rats
The oral administration of HCl/ethanol (60% in 150 mM HCl) produced multiple lesions in the
glandular mucosa, along the long axis of the rat stomach. These lesions were dose-dependently
prevented in animals pretreated with capsaicin (1-10 mg/kg) p.o. before the challenge with
HCl/ethanol, and a significant effect was obtained at doses over 3 mg/kg, with the inhibition
at 10 mg/kg being 81.6% (Figure 1A). The protective effects of capsaicin (10 mg/kg) were
completely attenuated by the chemical ablation of sensory neurons as well as prior adminis‐
tration of indomethacin (5 mg/kg), but not by ONO-AE-829 (10 mg/kg)(Figure 1B). The severity
of HCl/ethanol-induced gastric lesions was also significantly reduced by the prior i.v. admin‐
istration of PGE2 (0.03 mg/kg), with the inhibition being 82.1% (Figure 2). The protective effects
of PGE2 were significantly mitigated by the pretreatment with the EP1 antagonist, ONO-
AE-829 (10 mg/kg), but not by chemical deafferentation. The degree of protection afforded by
PGE2 in the presence of ONO-AE-829 at 10 mg/kg was 19.8%, which was significantly less than
that observed in vehicle-treated normal rats.
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Figure 1. Dose-response relationship for the protective effects of capsaicin against HCl/ethanol-induced gastric le‐
sions in rats (A), and the effects of indomethacin (5 mg/kg), ONO-AE-829 (10 mg/kg), or sensory deafferentation on
the mucosal protective effects of capsaicin (B). Animals were administered 1 ml of HCl/ethanol (60% in 150 mM HCl),
and killed 1 hr later. Capsaicin (1-10 mg/kg) was administered p.o. 30 min before HCl/ethanol. Indomethacin (5
mg/kg) or ONO-AE-829 (10 mg/kg) was given s.c. 30 min before capsaicin. Sensory deafferentation was achieved with
3 consecutive s.c. injections of capsaicin (total 100 mg/kg) 2 weeks before the experiment. Data are presented as




Figure 2. Effects of ONO-AE-829 or sensory deafferentation on the protective action of PGE2 against HCl/ethanol in
the rat stomach. Animals were administered 1 ml of HCl/ethanol (60% in 150 mM HCl), and killed 1 hr later. PGE2 (0.3
mg/kg) was given i.v. 10 min before HCl/ethanol. ONO-AE-829 (10 mg/kg) was administered s.c. 30 min before PGE2.
Sensory deafferentation was induced with 3 consecutive s.c. injections of capsaicin (total 100 mg/kg) 2 weeks before
the experiment. Data are presented as means±SE from 6-8 rats. Significantly different at P<0.05: *from the control; #
from the vehicle.
The oral administration of capsaicin (10 mg/kg) did not affect the mucosal PGE2 content when
measured 0.5 hr after its administration (not shown). The prior administration of indomethacin
(5 mg/kg, s.c.) markedly reduced PGE2 levels in the presence of capsaicin. As in normal rats,
capsaicin did not significantly affect mucosal PGE2 levels in sensory deafferented animals.
3.2. Reversal of capsaicin-induced protection by EP agonists in indomehtacin-pretreated
rats
To investigate the roles of PGE2 and EP receptors in capsaicin-induced gastric protection, we
examined the rescue effects of various subtype-specific EP agonists on capsaicin in the presence
of indomethacin. The oral administration of capsaicin (10 mg/kg) markedly protected against
HCl/ethanol-induced gastric lesions (Figure 3A). This effect of capsaicin was significantly
mitigated by the prior administration of indomethacin (5 mg/kg), and the degree of inhibition
was reduced to 29.7%. When these animals were given various EP agonists i.v. 20 min after
indomethacin, the protective effects of capsaicin were again observed in rats pretreated with
butaprost (an EP2 agonist). Neither ONO-NT-012 (an EP3 agonist) nor 11-deoxy PGE1 (an EP3/
EP4 agonist) rescued the effects of capsaicin against HCl/ethanol in the presence of indome‐
thacin. None of the EP agonists (i.v.) used, including butaprost, significantly protected against
HCl/ethanol by themselves (Figure 3B).
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Figure 3. A: Effects of various EP agonists on the mucosal protective action of capsaicin against HCl/ethanol-induced
gastric lesions in the rat stomach in the presence of indomethacin. Animals were given 1 ml of HCl/ethanol (60% in
150 mM HCl) and killed 1 hr later. Capsaicin (10 mg/kg) was administered p.o. 30 min before HCl/ethanol. Indome‐
thacin (5mg/kg) was given s.c. 30 min before capsaicin. Various EP agonists were given i.v. 10 min before capsaicin.
Data are presented as means±SE from 6-8 rats. Significantly different at P<0.05: *from the control; # from the saline; $
from vehicle. B: Effects of various EP agonists on HCl/ethanol-induced gastric lesions in the rat stomach. Various EP




3.3. Gastric cytoprotection against HCl/ethanol by capsaicin in mice
To further investigate the relationship between capsaicin-induced gastric protection and EP
receptor subtype, we examined the protective effects of capsaicin against HCl/ethanol in both
wild-type and knockout mice lacking EP1 or EP3 receptors. In addition, since other study
reported a role for PGI2 in the release of CGRP in the stomach following capsaicin stimulation
[19], the protective effect of capsaicin was also examined in IP receptor knockout mice. The
intragastric administration of HCl/ethanol (0.3 ml) also caused hemorrhagic lesions in the
mouse stomach (Figure 4). HCl/ethanol led to the development of gastric lesions in EP1, EP3,
and IP receptor knockout mice, similar to wild-type mice, and the severity of these lesions was
similar among these groups. The severity of these lesions in wild-type mice was also reduced
by the prior p.o. administration of capsaicin (10 mg/kg). This agent significantly reduced the
severity of these lesions in animals lacking either EP1 or EP3 receptors. However, capsaicin
failed to protect the stomach against HCl/ethanol in IP receptor knockout mice, and the lesion
score in these animals was not significantly different from that observed in IP receptor
knockout animals without the capsaicin pretreatment.
Figure 4. Effects of capsaicin on HCl/ethanol-induced gastric lesions in wild-type and knockout mice lacking EP1, EP3
or IP receptors. Animals were administered 0.3 ml of HCl/ethanol (60% ethanol in 150 mM HCl) p.o. and killed 1 hr
later. Capsaicin (10 mg/kg) was given p.o. 30 min before HCl/ethanol. In wild-type mice, indomethacin (5 mg/kg) was
given s.c. 30 min before administration of capsaicin. Data are presented as means±SE from 4-6 mice. Significantly dif‐
ferent at P<0.05; *from the vehicle in the corresponding group; # from saline.
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The oral administration of capsaicin (10 mg/kg) did not significantly affect 6-keto PGF1α levels,
which was similar to the effects observed on PGE2 content in the rat stomach (not shown).
Indomethacin (5 mg/kg) markedly decreased 6-keto PGF1α levels in the presence of capsaicin.
Similarly, capsaicin had no effect on 6-keto PGF1α levels in IP receptor knockout mice.
3.4. Effect of capsaicin on gastric mucosal blood flow in mice
Under urethane anesthesia, the chambered stomachs of both wild type mice and those lacking
EP1, EP3, or IP receptors showed a relatively constant GMBF during a 2-hr test period. The
mucosal application of capsaicin (1 mg/ml) for 10 min caused a marked increase in GMBF in
wild type mice, and this effect was significantly attenuated by the prior administration of
indomethacin (5 mg/ml) (Figure 5). A significant increase in GMBF by capsaicin was also
observed in both EP1 and EP3 receptor knockout mice. However, the gastric hyperemic
response to capsaicin was almost completely absent in animals lacking IP receptors, and GMBF
values were significantly lower than those in control wild type mice, at most of the time points
measured after the application of capsaicin.
Figure 5. Effects of capsaicin on GMBF in wild type mice and knockout mice lacking EP1, EP3 or IP receptors under
urethane anesthetized conditions. Capsaicin was applied to the chamber at a concentration of 1 mg/ml for 10 min
(100 µl), and GMBF was measured before and after its application. Indomethacin was administered s.c. at a dose of 5
mg/kg 30 min before capsaicin in wild-type mice. Data are expressed as an increase in GMBF (a % of basal values) and
presented as means±SE of values determined every 10 min from 5-6 mice per group. Significantly different at P<0.05:





PGs, either endogenous or exogenous derivatives, have been shown to act on multiple
receptors [12]. Capsaicin affords gastric protection by stimulating afferent C-fibers [3], and this
action is partly dependent on endogenous PGs [5, 8, 9, 24]. We previously examined the
relationship between EP receptor subtypes and gastric protection against HCl/ethanol in rats
using various EP agonists and found that the gastroprotective action afforded by endogenous
or exogenous PGs was mediated by EP1 receptors [16, 17]. However, the EP receptor subtypes
or other prostanoid receptors responsible for this phenomenon has yet to be established. The
present study was conducted to determine the prostanoid receptor(s) involved in capsaicin-
induced gastric protection.
First, we confirmed that PGE2 prevented the development of HCl/ethanol-induced gastric
lesions, and this action was attenuated by the EP1 antagonist, ONO-AE-829 [16]. This result
was also verified in EP receptor knockout mice, with this protection being completely absent
in mice lacking EP1 receptors [16, 17]. These results strongly suggest that the protective effects
of exogenous PGE2 in the stomach were mainly mediated by the activation of EP1 receptors.
On the other hand, endogenous PGs play a role in the gastric cytoprotection induced by the
oral administration of capsaicin [5, 8, 9]. As shown in this study, the protective effects of
capsaicin against HCl/ethanol were dose-dependent, and were attenuated by the chemical
ablation of capsaicin-sensitive sensory neurons. The protective effects of capsaicin were also
significantly mitigated by the prior administration of indomethacin, which indicated the
involvement of endogenous PGs in these effects. However, in contrast to the adaptive
cytoprotection induced by a mild irritant [17], the effects of capsaicin were not affected by the
selective EP1 antagonist, ONO-AE-829. This was confirmed by the stimulatory effects of
capsaicin on gastric HCO3-secretion which were attenuated by indomethacin and capsazepine,
but not ONO-8711 (an EP1 antagonist) [25]. Furthermore, neither the stimulation of sensory
neurons by capsaicin nor sensory deafferentation affected mucosal PGE2 levels in the stomach.
Many studies have shown that mild irritants increased the production of PGE2 in the stomach
[14, 17]. These findings suggest that although endogenous PGs are involved in the gastric
cytoprotection induced by both mild irritants and capsaicin, the mode of action appears to be
different in these two cases. The stimulation of afferent neurons by capsaicin was assumed to
increase the production of PGs in the stomach, but exerted protective effects in the stomach,
that were partly dependent on endogenous PGs.
In the present study, we administered various EP agonists to indomethacin-treated animals,
to determine whether the inhibitory effect of indomethacin on capsaicin-induced gastric
protection was reversed by exogenous PGE2, and if so, which EP receptor subtype was
responsible for this action. The protective effects of capsaicin were significantly restored, even
in the presence of indomethacin, by the prior administration of butaprost, the EP2 agonist, but
not by the EP3 or EP4 agonist. In addition, the protective effects of capsaicin were significantly
enhanced in the presence of butaprost, which strongly suggested a supportive role for EP2
receptors in capsaicin-induced gastric protection. These results are supported by the findings
of Haupt et al [26], who reported the involvement of the EP2 receptor in the potentiation of
afferent neuronal discharges by PGE2 in the rat jejunum. Jenkins et al [27] also demonstrated
that the activation of DP, EP, and IP receptors could each cause the release of CGRP from
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trigeminal neurons, and that the predominant EP receptor subtype involved may be the EP2
receptor. In the present study, neither of these EP agonists, including butaprost, offered any
protection against HCl/ethanol-induced gastric damage by themselves. Furthermore, capsai‐
cin-induced gastric protection was not affected by the EP1 antagonist, which excluded the
involvement of EP1 receptors in the facilitation of this action by endogenous PGs. The
significant level of protection afforded by capsaicin was also observed in knockout mice
lacking EP1 and EP3 receptors, which confirmed that capsaicin-induced gastric protection did
not involve EP1 or EP3 receptors. We could not confirm the involvement of EP2 receptors in
this action because EP2 knockout mice were not available in our laboratory.
In contrast, we demonstrated that capsaicin failed to exhibit a cytoprotective effect against
HCl/ethanol-induced gastric lesions in IP-receptor knockout mice. We previously showed that
20 mM taurocholate, as a mild irritant, protected the stomach against HCl/ethanol even in IP
receptor knockout mice, which was similar to that observed in wild-type mice. These results
suggested the absence of the involvement of PGI2 in the mechanism responsible for adapative
cytoprotection [17]. We also reported that the adaptive cytoprotection induced by taurocholate
was attenuated by ONO-AE-829, the EP1 antagonist, as well as indomethacin, and was not
observed in EP1 receptor knockout mice [17]. The present results obtained in knockout mice
suggest that IP receptors are also involved in the protective effects of capsaicin in the stomach,
in addition to EP2 receptors. The exact mechanism by which endogenous PGs contributes to
the protective action of capsaicin is currently unknown. Previous studies have suggested that
endogenous PGs may sensitize sensory neurons to nociceptive stimuli [10, 11]. Boku et al. [19]
reported the lack of CGRP release in response to mild injuries in the stomachs of IP-receptor
knockout mice. Oishi et al. [10] demonstrated, using IP-receptor knockout mice, that PGI2 was
a major nociceptive mediator in the acetic acid-induced writhing reaction. Since capsaicin-
induced gastric cytoprotection was attenuated by indomethacin and was absent in IP-receptor
knockout mice, endogenous PGI2 may play a supportive role in the mechanism responsible
for capsaicin-induced gastric cytoprotection, possibly by sensitizing sensory neurons [17, 28].
However, capsaicin did not have any effect on either PGE2 production in the rat stomach or
PGI2 production in the mouse stomach. Thus, PGs generated constitutively may maintain the
sensitivity of these neurons to the capsaicin stimulation.
Intragastric capsaicin has been shown to increase GMBF in the rat stomach, and this effect was
attenuated by sensory deafferentation following a capsaicin pretreatment [9, 14, 29]. Although
gastric hyperemia is not the exclusive mechanism responsible for gastric cytoprotection
induced by PGE2 or the stimulation of capsaicin-sensitive afferent neurons [16, 30], GMBF is
considered to be a factor in capsaicin-induced gastric protection under certain experimental
conditions [7, 29]. We previously reported that the gastric hyperemic response to capsaicin
was also significantly mitigated by indomethacin, which suggested the involvement of
endogenous PGs in this response [14]. In the present study, we confirmed that intragastric
capsaicin markedly increased GMBF in wild type mice in an indomethacin-sensitive manner.
This effect was also observed in EP1 or EP3 receptor knockout mice, but was completely absent
in animals lacking IP receptors, similar to the gastroprotective effects of capsaicin. These results
may provide functional evidence for the modulatory role of IP receptors in the facilitation of




The results of the present study suggest that capsaicin exhibits gastric cytoprotective effects
as well as gastric hyperemic response, essentially by stimulating sensory neurons, and this
partly depended on endogenous PG levels. The facilitative effects of endogenous PGs were
mediated by EP2 and IP receptors, which may have sensitized the sensory neurons to capsaicin,
even though capsaicin increased the production of PGI2 but not PGE2 in the gastric mucosa.
However, whether endogenous PGs modulated the effects of capsaicin by interacting with
TRPV1 remains unknown; however, capsaicin previously exhibited gastric protective effects
by activating TRPV1 [31]. Endogenous phosphatidyl-inositol-4, 5-bisphosphate (PtdIns(4, 5)
P2) was shown to inhibit TRPV1, and this was alleviated by agents that activated phospholipase
C [32, 33]. Therefore, PGs may sensitize these afferent neurons to capsaicin through EP2/IP
receptors by somehow releasing TRPV1 from PtdIns(4, 5)P2-mediated inhibition.
5. Summary
Capsaicin provided gastric cytoprotection essentially through the stimulation of sensory
neurons, and this partly depended on endogenous PGs. PGs facilitated the protective effects
of capsaicin, and this response was mediated by EP2 and IP receptors, possibly by sensitizing
the sensory neurons to capsaicin, even though capsaicin increased the production of PGI2 but
not PGE2 in the gastric mucosa (Figure 6). Although endogenous PGs are also known to be
involved in the adaptive cytoprotection induced by mild irritants, this is different from that of
capsaicin and is mediated by the activation of EP1 receptors with a concomitant increase in
the production of mucosal PGE2.
Figure 6. Mechanisms underlying the gastric cytoprotection induced by PGE2, mild irritants, and capsaicin. Exogenous
PGE2 provides direct gastric cytoprotection, and this was mediated by the activation of EP1 receptors and completely
blocked by the EP1 antagonist, ONO-AE-829. A mild irritant increased endogenous PGE2 production in the stomach
and exhibited adaptive gastric cytoprotection. This action was prevented by indomethacin as well as the EP1 antago‐
nist. On the other hand, capsaicin exhibited gastric cytoprotective effects, essentially mediated by capsaicin-sensitive
afferent neurons via the activation of TRPV1 receptors, and this effect was completely attenuated by the TRPV1 antag‐
onist, capsazepine. Although capsaicin increased the production of PGI2 but not PGE2 in the gastric mucosa, this pro‐
tective effect was facilitated by endogenous PGs through PGE2/EP2 and PGI2/IP receptors.
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